These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2201500)

  • 1. Cyclosporin therapy for prevention and cure of IDDM. Epidemiological perspective of benefits and risks.
    Lipton R; LaPorte RE; Becker DJ; Dorman JS; Orchard TJ; Atchison J; Drash AL
    Diabetes Care; 1990 Jul; 13(7):776-84. PubMed ID: 2201500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials of cyclosporin in IDDM.
    Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
    Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.
    Diabetes; 1988 Nov; 37(11):1574-82. PubMed ID: 2903105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
    Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T
    Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
    Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE
    Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression in IDDM. Rationale, risks, benefits, and strategies.
    Mahon JL; Dupré J; Stiller CR; Donner AP
    Diabetes Care; 1990 Jul; 13(7):806-8. PubMed ID: 2201503
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of cyclosporin A therapy in the early phase of type I diabetes mellitus].
    Schernthaner G; Aschauer-Treiber G; Gaube S; Klösch-Kasparek D; Müller C; Zielinski C
    Wien Klin Wochenschr; 1988 Jun; 100(13):454-9. PubMed ID: 3043916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in type I diabetes. Approaches to prevention and treatment.
    Colman PG; Eisenbarth GS
    Postgrad Med; 1987 May; 81(6):146-55. PubMed ID: 3554198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.
    Feutren G; Papoz L; Assan R; Vialettes B; Karsenty G; Vexiau P; Du Rostu H; Rodier M; Sirmai J; Lallemand A
    Lancet; 1986 Jul; 2(8499):119-24. PubMed ID: 2873396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
    Bougnères PF; Landais P; Boisson C; Carel JC; Frament N; Boitard C; Chaussain JL; Bach JF
    Diabetes; 1990 Oct; 39(10):1264-72. PubMed ID: 2210078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression in autoimmune disease: the double-edged sword.
    Jaworski MA; Jewell LD; Honore L; Mehta JG; Bayens-Simmonds J; McGuire-Clark P; Schouls JJ; Yap WY
    Clin Invest Med; 1987 Sep; 10(5):488-95. PubMed ID: 3315371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclosporin on interleukin 2-related T-lymphocyte parameters in IDDM patients.
    Chatenoud L; Feutren G; Nelson DL; Boitard C; Bach JF
    Diabetes; 1989 Feb; 38(2):249-56. PubMed ID: 2644144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclosporin and autoimmune diseases. 2: Human autoimmune diseases].
    Feutren G; Bach JF
    Rev Med Interne; 1987; 8(1):99-107. PubMed ID: 3550988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin for diabetes?
    Lancet; 1986 Jul; 2(8499):140. PubMed ID: 2873403
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin-dependent diabetes: strategy for immune intervention.
    Debray-Sachs M; Feutren G; Boitard C; Assan R; Bach JF
    Exp Clin Endocrinol; 1987 Aug; 89(3):297-300. PubMed ID: 3666048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induction of remissions of insulin-dependent diabetes by cyclosporin].
    Feutren G; Papoz L; Assan R; Vialettes B; Pehuet M; Vexiau P; Durostu H; Rodier M; Sirmai J; Lallemand A
    C R Acad Sci III; 1986; 303(8):295-7. PubMed ID: 3094846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary multicentre study of the treatment of recently diagnosed type 1 diabetes by combination nicotinamide-cyclosporin therapy.
    Vialettes B; Picq R; du Rostu M; Charbonnel B; Rodier M; Mirouze J; Vexiau P; Passa P; Pehuet M; Elgrably F
    Diabet Med; 1990; 7(8):731-5. PubMed ID: 2147636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects.
    Martin S; Schernthaner G; Nerup J; Gries FA; Koivisto VA; Dupré J; Standl E; Hamet P; McArthur R; Tan MH
    Diabetologia; 1991 Jun; 34(6):429-34. PubMed ID: 1884902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunosuppression in juvenile diabetes mellitus? Critical viewpoint on the treatment with cyclosporin A with consideration of the differential etiology].
    Teuber J; Usadel KH
    Fortschr Med; 1985 Jul; 103(27-28):707-13. PubMed ID: 4029865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.